BioMarin Pharmaceuticals
BMRN • NASDAQ • Stock Fundamentals
BioMarin Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alexander Hardy, with a market cap of $10.7B.
Market Cap$10.7B
Employees3.4K
CEOAlexander Hardy
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 4, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 3, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
BioMarin Pharmaceuticals FAQ
Common questions about BioMarin Pharmaceuticals
BioMarin Pharmaceuticals (BMRN) has a market capitalization of $10.7B and trades on NASDAQ.
BioMarin Pharmaceuticals has approximately 3,401 employees.